MONROVIA, Liberia (AP) -- The Liberian government says it will receive doses of an experimental Ebola drug to treat doctors in the West African country.
The U.S. government confirmed that it had put Liberian officials in touch with the maker of ZMapp, and referred additional questions to Mapp Biopharmaceutical Inc.
It was unclear how much of the treatment would be sent but government officials cautioned that the company had only a limited supply of the drug. The company said in a statement Monday that its supply had been exhausted.
Thus far, two Americans and a Spaniard have received the drug.
An outbreak of Ebola in West Africa has killed around 960 people so far.